Haemonetics Operating Margin 2010-2025 | HAE

Current and historical operating margin for Haemonetics (HAE) over the last 10 years. The current operating profit margin for Haemonetics as of March 31, 2025 is 17.01%.
Haemonetics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.36B $0.22B 16.30%
2024-12-31 $1.37B $0.18B 13.17%
2024-09-30 $1.36B $0.17B 12.34%
2024-06-30 $1.33B $0.15B 11.33%
2024-03-31 $1.31B $0.17B 12.61%
2023-12-31 $1.27B $0.17B 13.40%
2023-09-30 $1.24B $0.17B 13.49%
2023-06-30 $1.22B $0.18B 14.71%
2023-03-31 $1.17B $0.16B 13.37%
2022-12-31 $1.13B $0.14B 12.41%
2022-09-30 $1.08B $0.13B 12.28%
2022-06-30 $1.03B $0.11B 10.82%
2022-03-31 $0.99B $0.08B 8.15%
2021-12-31 $0.95B $0.04B 4.30%
2021-09-30 $0.93B $0.05B 4.82%
2021-06-30 $0.90B $0.08B 8.75%
2021-03-31 $0.87B $0.09B 10.34%
2020-12-31 $0.88B $0.14B 15.52%
2020-09-30 $0.90B $0.14B 15.30%
2020-06-30 $0.95B $0.13B 13.64%
2020-03-31 $0.99B $0.10B 10.53%
2019-12-31 $1.00B $0.10B 10.21%
2019-09-30 $0.99B $0.09B 9.02%
2019-06-30 $0.98B $0.07B 6.66%
2019-03-31 $0.97B $0.08B 8.58%
2018-12-31 $0.95B $0.07B 7.67%
2018-09-30 $0.94B $0.05B 4.90%
2018-06-30 $0.92B $0.04B 4.77%
2018-03-31 $0.90B $0.06B 6.19%
2017-12-31 $0.90B $-0.02B -1.78%
2017-09-30 $0.89B $0.00B 0.45%
2017-06-30 $0.89B $0.00B 0.56%
2017-03-31 $0.89B $-0.02B -2.26%
2016-12-31 $0.90B $0.03B 3.56%
2016-09-30 $0.91B $-0.05B -5.52%
2016-06-30 $0.91B $-0.06B -6.19%
2016-03-31 $0.91B $-0.04B -4.85%
2015-12-31 $0.89B $-0.03B -2.91%
2015-09-30 $0.89B $0.05B 5.95%
2015-06-30 $0.90B $0.05B 5.12%
2015-03-31 $0.91B $0.04B 4.40%
2014-12-31 $0.93B $0.04B 4.32%
2014-09-30 $0.94B $0.04B 4.28%
2014-06-30 $0.94B $0.05B 5.41%
2014-03-31 $0.94B $0.05B 4.90%
2013-12-31 $0.95B $0.05B 5.49%
2013-09-30 $0.95B $0.05B 5.25%
2013-06-30 $0.94B $0.04B 3.96%
2013-03-31 $0.89B $0.06B 6.40%
2012-12-31 $0.83B $0.06B 7.25%
2012-09-30 $0.77B $0.07B 8.94%
2012-06-30 $0.73B $0.08B 10.64%
2012-03-31 $0.73B $0.09B 12.23%
2011-12-31 $0.71B $0.10B 13.64%
2011-09-30 $0.70B $0.10B 14.49%
2011-06-30 $0.69B $0.11B 16.20%
2011-03-31 $0.68B $0.11B 16.40%
2010-12-31 $0.68B $0.09B 12.72%
2010-09-30 $0.66B $0.08B 12.50%
2010-06-30 $0.65B $0.08B 12.39%
2010-03-31 $0.65B $0.08B 12.87%
2009-12-31 $0.63B $0.10B 15.45%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.592B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.464B 25.98
Boston Scientific (BSX) United States $155.948B 37.25
Stryker (SYK) United States $144.198B 29.40
EssilorLuxottica (ESLOY) France $136.878B 0.00
Medtronic (MDT) Ireland $114.582B 16.24
Lonza Group Ag (LZAGY) Switzerland $48.915B 0.00
Haleon (HLN) United Kingdom $43.396B 24.77
ResMed (RMD) United States $40.938B 29.24
Agilent Technologies (A) United States $32.241B 21.02
GE HealthCare Technologies (GEHC) United States $31.891B 14.99
Koninklijke Philips (PHG) Netherlands $25.479B 16.85
Terumo (TRUMY) Japan $25.170B 32.69
Insulet (PODD) United States $20.051B 78.70
Zimmer Biomet Holdings (ZBH) United States $17.929B 11.51
Smith & Nephew SNATS (SNN) United Kingdom $13.503B 0.00
Baxter (BAX) United States $11.269B 8.71
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.745B 28.29
Lantheus Holdings (LNTH) United States $4.882B 12.32
Perrigo (PRGO) Ireland $3.662B 9.28
Prestige Consumer Healthcare (PBH) United States $3.643B 16.27
Envista Holdings (NVST) United States $3.530B 24.22
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.136B 23.12
LeMaitre Vascular (LMAT) United States $1.831B 40.93
AtriCure (ATRC) United States $1.710B 0.00
QuidelOrtho (QDEL) United States $1.543B 10.61
Green Thumb Industries (GTBIF) United States $1.429B 32.14
Acuren (TIC) United States $1.340B 0.00
AdaptHealth (AHCO) United States $1.181B 11.99
Phibro Animal Health (PAHC) United States $1.058B 13.53
Neogen (NEOG) United States $1.012B 16.07
BioLife Solutions (BLFS) United States $0.995B 0.00
Curaleaf Holdings (CURLF) Canada $0.954B 0.00
InMode (INMD) Israel $0.868B 8.04
Kestra Medical Technologies (KMTS) United States $0.790B 0.00
Valneva SE (VALN) France $0.614B 0.00
Evolus (EOLS) United States $0.590B 0.00
Tilray Brands (TLRY) Canada $0.572B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
ZimVie (ZIMV) United States $0.522B 20.39
Surmodics (SRDX) United States $0.515B 0.00
CeriBell (CBLL) United States $0.511B 0.00
Owens & Minor (OMI) United States $0.508B 4.21
SNDL (SNDL) Canada $0.434B 0.00
Capricor Therapeutics (CAPR) United States $0.361B 0.00
Sanuwave Health (SNWV) United States $0.311B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Cresco Labs (CRLBF) United States $0.304B 0.00
VAREX IMAGING (VREX) United States $0.296B 10.88
Quanterix (QTRX) United States $0.293B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.67
Cerus (CERS) United States $0.243B 0.00
Verano Holdings (VRNOF) United States $0.239B 0.00
Viemed Healthcare (VMD) United States $0.234B 19.77
OraSure Technologies (OSUR) United States $0.225B 0.00
Omeros (OMER) United States $0.223B 0.00
Brainsway (BWAY) Israel $0.217B 57.35
Canopy Growth (CGC) Canada $0.215B 0.00
Sanara MedTech (SMTI) United States $0.215B 0.00
Biote (BTMD) United States $0.213B 5.98
Vireo Growth (VREOF) United States $0.196B 0.00
Exagen (XGN) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.69
Organigram Global (OGI) Canada $0.178B 0.00
High Tide (HITI) Canada $0.176B 0.00
TriSalus Life Sciences (TLSI) United States $0.158B 0.00
TerrAscend (TSNDF) Canada $0.132B 0.00
Safety Shot (SHOT) United States $0.122B 0.00
Jushi Holdings (JUSHF) United States $0.118B 0.00
FitLife Brands (FTLF) United States $0.117B 14.45
Quipt Home Medical (QIPT) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.097B 12.51
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.072B 0.00
Agape ATP (ATPC) $0.067B 0.00
Apyx Medical (APYX) United States $0.066B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.054B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Zynex (ZYXI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.71
Nephros (NEPH) United States $0.036B 48.86
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
IM Cannabis (IMCC) Canada $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00